Monday, December 23, 2024
HomeTagsBruton's Tyrosine Kinase inhibitor

Bruton's Tyrosine Kinase inhibitor

AbbVie Advances Upadacitinib (RINVOQ) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

AbbVie announced topline results from a Phase 2 study of upadacitinib given alone or as combination therapy (ABBV-599) with a Bruton's Tyrosine Kinase inhibitor (elsubrutinib,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics